Laddar...
CYP27B1 Downregulation: A New Molecular Mechanism Regulating EZH2 in Ovarian Cancer Tumorigenicity
BACKGROUND: Ovarian cancer has the highest mortality rate among gynecologic cancers, and most patients are diagnosed in advanced stages. Enhancer of zeste homolog 2 (EZH2) is a major tumor marker and an effective therapeutic target for ovarian cancer, but the underlying molecular mechanism remains u...
Sparad:
| I publikationen: | Front Cell Dev Biol |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Frontiers Media S.A.
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7591459/ https://ncbi.nlm.nih.gov/pubmed/33163485 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2020.561804 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|